Dr. Shelita Dattani is the Director, Practice Development and Knowledge Translation, at the Canadian Pharmacists Association.
Sheli received her bachelor of science in pharmacy from Northeastern University and her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill. She has worked in numerous practice settings in the US and Canada where she has led dynamic teams towards excellence in effective and safe best medication practice. Sheli has also held teaching appointments at the University of Ottawa and the University of Waterloo. She has authored several articles and book chapters and has presented in various capacities at provincial, national and international conferences.
For the past two and a half years, Sheli has provided leadership towards a national vision for evidence informed practice development to support the advancement of pharmacists practice in Canada. Within her portfolio, she is also responsible for leading the transfer and mobilization of pharmacy practice research knowledge to the pharmacy community to support practice advancement and enhance patient care. Sheli is also responsible for providing overall portfolio leadership in the professional and research streams of the national Canadian Pharmacists Conference.
Sheli maintains a part-time practice in community pharmacy and remote hospital telepharmacy. She is a member of several professional organizations and holds an active pharmacist license in the province of Ontario
Sheli has a strong interest and passion for advancement of the pharmacy profession in the provision of excellence in patient care.
In 2017, as part of her role at CPhA, Sheli presented remarks to the federal health committee on the topic of medical cannabis and the role of the pharmacist. Also in 2017, Sheli also served as an expert panelist on an ipolitics public affairs panel discussing the role of pharmacists in advising and dispensing medical cannabis to patients. Sheli has also given lectures to fourth year University of Waterloo students covering the therapeutics, evidence and potential role of the pharmacist in care of patients using cannabis for medical purposes., Sheli has served as a peer reviewer on several CPhA practice tools and resources on the topic of medical cannabis and has devliered numerous conference presentations on both the therapeutics of cannabis and from an advocacy perspective discussing the role of pharmacists in providing care to patients on medical cannabis.